Cargando…
Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204986/ https://www.ncbi.nlm.nih.gov/pubmed/35715788 http://dx.doi.org/10.1186/s12885-022-09764-1 |
_version_ | 1784729035060805632 |
---|---|
author | Yamaguchi, Fuminori Hirata, Yuko Akram, Hossain Kamitori, Kazuyo Dong, Youyi Sui, Li Tokuda, Masaaki |
author_facet | Yamaguchi, Fuminori Hirata, Yuko Akram, Hossain Kamitori, Kazuyo Dong, Youyi Sui, Li Tokuda, Masaaki |
author_sort | Yamaguchi, Fuminori |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9204986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92049862022-06-18 Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 Yamaguchi, Fuminori Hirata, Yuko Akram, Hossain Kamitori, Kazuyo Dong, Youyi Sui, Li Tokuda, Masaaki BMC Cancer Editorial Expression of Concern BioMed Central 2022-06-17 /pmc/articles/PMC9204986/ /pubmed/35715788 http://dx.doi.org/10.1186/s12885-022-09764-1 Text en © BioMed Central 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Editorial Expression of Concern Yamaguchi, Fuminori Hirata, Yuko Akram, Hossain Kamitori, Kazuyo Dong, Youyi Sui, Li Tokuda, Masaaki Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title | Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title_full | Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title_fullStr | Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title_full_unstemmed | Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title_short | Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 |
title_sort | editorial expression of concern: foxo/txnip pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist mk-801 |
topic | Editorial Expression of Concern |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204986/ https://www.ncbi.nlm.nih.gov/pubmed/35715788 http://dx.doi.org/10.1186/s12885-022-09764-1 |
work_keys_str_mv | AT yamaguchifuminori editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT hiratayuko editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT akramhossain editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT kamitorikazuyo editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT dongyouyi editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT suili editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 AT tokudamasaaki editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801 |